Pms3 - Infliximab for Disease-Modifying Anti-Rheumatic Drug-Naive Rheumatoid Arthritis Patients: Systematic Review and Descriptive Analysis of Publications of Randomized Controlled Trials
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1717
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV